This study focused on the role of SIRT4 in the tamoxifen sensitivity of breast cancer and demonstrated that SIRT4 blocks the transcription and translation of MYC and CCND1 in ER‐positive breast cancer, through the STAT3 pathway. Here, CCND1 is linked to breast carcinoma.